
P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY
Author(s) -
Oñate G.,
Pratcorona M.,
Garrido A.,
Artigas A.,
Bataller A.,
Tormo M.,
Arnan M.,
Vives S.,
Coll R.,
Salamero O.,
VallLlovera F.,
Sampol A.,
Garcia A.,
Cervera M.,
Garcia Avila S.,
Bargay J.,
Ortin X.,
Esteve J.,
Sierra J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845148.20140.63
Subject(s) - medicine , midostaurin , oncology , npm1 , cumulative incidence , hematopoietic stem cell transplantation , transplantation , myeloid leukemia , cohort , cytarabine , biology , biochemistry , karyotype , chromosome , gene